Market Cap
$84.3B
ELV
Elevance Health, Inc.
$386.22 ▲ +1.19%
Prev close $381.67Market cap$84.3B
ConsensusBuy
12-mo target$451.38 (+16.9%)
▲ Bullish
Analyst conviction 7/10
Insider Buying Cluster (2 insiders)High Impact Filing (7/10)35 New Institutional Positions15 Institutional Exits Traditional Finance
Snapshot
The big-picture read on ELV right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (66%)
Inst. Holders
50 funds
Inst. Value
$56.1B
Inst. Activity
35 buys / 15 sells
Insider Activity
$2.2M buy / $1.7M sell
Insider Net $
$493.1K
Social Sentiment
71° Bullish
SEC Reports
12
Congressional
1 trades
Price chart 30d -4.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 10, 2026 SEC Aug 22, 2026 SEC
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during upcoming investor meetings. The company expe
8-K — Impact 3/10
Sep 10, 2026 short_volume
Short Volume: ELV — 56.3% short (0.5M / 0.8M)
Short: 464,836 | Exempt: 4,226 | TRF Vol: 825,690 | Short Ratio: 56.3% | Off-exchange volume (dark p
Sep 3, 2026 Insider
Wessling Erin M surrendered for taxes 255 shares
EVP & Chief Legal Officer @ $414.78 ($105.8K)
Sep 2, 2026 Insider
Craig Ryan R surrendered for taxes 144 shares
EVP & Chief HR Officer @ $405.84 ($58.4K)
Sep 2, 2026 Insider
Aug 27, 2026 SEC Wessling Erin M surrendered for taxes 94 shares
EVP & Chief Legal Officer @ $405.84 ($38.1K)
A massive institutional cluster reveals strong bullish conviction in Elevance Health during 2026-Q2, with 87 buyers accu
INST-CLUSTER — Impact 6/10
A federal magistrate judge granted plaintiff Wiegman's motion to compel Elevance Health to produce 52 emails to the Indi
COURT-RULING — Impact 2/10
Aug 20, 2026 Event
WIEGMAN v. ELEVANCE HEALTH, INC.
Court ruling (insd) — Docket: 1:24-cv-01930
Analyst ratings buy % +22.2%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
66% rate it Buy or better · 29 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Jul 17, 2026 | Bernstein | MAINTAIN | Outperform | 51% |
| Jul 17, 2026 | Leerink Partners | MAINTAIN | Market Perform | 49% |
| Jul 16, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
| Jul 16, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Jul 16, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Jul 16, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Jul 16, 2026 | Baird | MAINTAIN | Neutral | 54% |
| Jul 14, 2026 | TD Cowen | MAINTAIN | Buy | 56% |
| Jul 14, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
| Jul 13, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 7 | 12 | 10 | 0 | 0 | 66% | |
| Aug 1, 2026 | 7 | 12 | 10 | 0 | 0 | 66% | |
| Jul 1, 2026 | 6 | 12 | 11 | 0 | 0 | 62% | |
| Jun 1, 2026 | 6 | 11 | 12 | 0 | 0 | 59% | |
| May 1, 2026 | 6 | 10 | 13 | 0 | 0 | 55% | |
| Apr 1, 2026 | 5 | 10 | 13 | 0 | 0 | 54% | |
| Mar 1, 2026 | 5 | 10 | 13 | 0 | 0 | 54% | |
| Feb 1, 2026 | 5 | 11 | 12 | 0 | 0 | 57% |
Price targets
Where 21 covering analysts think ELV trades over the next 12 months.
$451.38 +16.9% upside Buy
Current$386.22 Low$393.00 Median$460.00 High$492.00 21 analysts
$393.00$492.00
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
71°
Bullish
BearishNeutralBullish
Recent posts
"They Sell for Many Reasons, But They Only Buy for One.." (Here are 4 Undervalued Stocks That Insiders are Buying Heavily in 2026)
▲ 1 · 💬 7· ⚡ 0.5
ELV CEO and the chairman both bought Friday, right after that Q2 selloff. Anyone else looking at it?
▲ 1 · 💬 2· ⚡ 0.5
Seeing fairly wide dispersion in short-term moves across some mid and large-cap names recently
▲ 1 · 💬 0· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
12 SEC filing reports analyzed · 1 bullish, 1 bearish, 1 mixed, 9 neutral · avg impact 3.4/10.
NEUTRAL8-K3/10
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during upcoming investor meetin
Sep 10, 2026
BULLISHINST-CLUSTER6/10
A massive institutional cluster reveals strong bullish conviction in Elevance Health during 2026-Q2,
Aug 27, 2026
NEUTRALCOURT-RULING2/10
A federal magistrate judge granted plaintiff Wiegman's motion to compel Elevance Health to produce 5
Aug 22, 2026
NEUTRALCOURT-RULING1/10
A federal magistrate judge issued an order requiring Elevance Health to show cause why a removed sta
Aug 18, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 10, 2026
short_volume
Short Volume: ELV — 56.3% short (0.5M / 0.8M)
Short: 464,836 | Exempt: 4,226 | TRF Vol: 825,690 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)
Sep 7, 2026
dark_pool
Dark Pool: ELV — 1.7M shares, 56,423 trades
Week starting 2026-09-07. Total ATS volume: 1,737,736 shares across 56,423 trades.
Aug 31, 2026
dark_pool
Dark Pool: ELV — 1.2M shares, 48,745 trades
Week starting 2026-08-31. Total ATS volume: 1,239,728 shares across 48,745 trades.
Aug 24, 2026
dark_pool
Dark Pool: ELV — 0.9M shares, 43,889 trades
Week starting 2026-08-24. Total ATS volume: 867,310 shares across 43,889 trades.
Aug 20, 2026
Enforcement
WIEGMAN v. ELEVANCE HEALTH, INC.
Court ruling (insd) — Docket: 1:24-cv-01930
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $4.66 | $4.55–$4.99 | -22.7% | -0.1% | 3↑ 14↓ | $49.1B | 19 |
| Next Q | $2.43 | $1.91–$3.31 | -27.0% | -1.5% | 0↑ 1↓ | $48.1B | 20 |
| Current FY | $27.17 | $27.00–$28.25 | -10.3% | +0.0% | 0↑ 1↓ | $196.6B | 22 |
| Next FY | $29.54 | $29.00–$31.00 | 8.7% | -0.2% | 2↑ 0↓ | $200.3B | 22 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $4.661 | — |
| 7d ago | $4.665 | -0.004 |
| 30d ago | $4.665 | -0.004 |
| 60d ago | $4.671 | -0.010 |
| 90d ago | $5.097 | -0.436 |
Institutional ownership
Which big funds own ELV (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $56.1B total value (145,172,426 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 35 institutions added/increased vs 15 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 18,991,090 | $7.3B | 13.1% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 14,058,204 | $5.4B | 9.7% | — |
| STATE STREET CORP | 10,426,610 | $4.0B | 7.2% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 9,213,513 | $3.6B | 6.3% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,214,356 | $2.4B | 4.3% | — |
| Sanders Capital, LLC | 5,825,024 | $2.3B | 4.0% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 5,166,124 | $2.0B | 3.5% | — |
| HARRIS ASSOCIATES L P | 4,924,511 | $1.9B | 3.4% | — |
| Artisan Partners Limited Partnership | 4,581,222 | $1.8B | 3.2% | — |
| Invesco Ltd. | 4,234,231 | $1.6B | 2.9% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 3,958,856 | — | $1.5B |
| FMR LLC | ADD | 1,975,719 | 3,131,652 | +58.5% | $1.2B |
| CITIGROUP INC | DOUBLED | 238,850 | 2,096,863 | +777.9% | $810.9M |
| GOLDMAN SACHS GROUP INC | ADD | 1,476,183 | 2,005,613 | +35.9% | $775.6M |
| BANK OF AMERICA CORP /DE/ | TRIM | 2,718,766 | 1,806,267 | -33.6% | $698.5M |
| Amundi | TRIM | 2,693,664 | 1,644,537 | -38.9% | $636.0M |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 2,078,364 | 1,528,416 | -26.5% | $591.1M |
| CITADEL ADVISORS LLC | TRIM | 1,562,219 | 906,386 | -42.0% | $350.5M |
| Capital International Investors | TRIM | 1,050,861 | 751,772 | -28.5% | $290.7M |
| ROYAL BANK OF CANADA | ADD | 495,383 | 694,935 | +40.3% | $268.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
18 insiders, 50 transactions. Net $493.1K — $2.2M bought, $1.7M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Wessling Erin M | EVP & Chief Legal Officer | TAX W/H | 255 | $414.78 | $105.8K |
| Sep 2, 2026 | Craig Ryan R | EVP & Chief HR Officer | TAX W/H | 144 | $405.84 | $58.4K |
| Sep 2, 2026 | Wessling Erin M | EVP & Chief Legal Officer | TAX W/H | 94 | $405.84 | $38.1K |
| Jul 17, 2026 | PERU RAMIRO G | Director | BUY | 1,000 | $366.05 | $366.1K |
| Jul 17, 2026 | BOUDREAUX GAIL | President and CEO | BUY | 680 | $366.41 | $249.2K |
| Jul 17, 2026 | BOUDREAUX GAIL | President and CEO | BUY | 2,045 | $368.25 | $753.1K |
| Jun 12, 2026 | Penczek Ronald W | CAO & Controller | SELL | 369 | $403.16 | $148.8K |
| Jun 11, 2026 | Dixon Robert L JR | Director | SELL | 151 | $401.77 | $60.7K |
| May 19, 2026 | Penczek Ronald W | CAO & Controller | EXERCISE | 877 | $311.48 | $273.2K |
| May 19, 2026 | Penczek Ronald W | CAO & Controller | SELL | 1,531 | $403.13 | $617.2K |
Congressional trades
ELV trades disclosed by members of Congress, with disclosure delay.
1 members · 1 buys / 0 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Markwayne Mullin | R | SENATE | BUY | $15,001 - $50,000 | Elevance Health Inc | Jan 16, 2026(19d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ELV.
Shares short
5,335,623
Settlement Sep 15, 2026
Change vs prior
-2.7%
Semi-monthly cycle
Days to cover
4.2
At avg daily volume
Of shares outstanding
≈2.5%
Estimate — not % of float
All ELV filing & press-release reports (12)
- 8-K reportSep 10, 2026
- INST-CLUSTER reportAug 27, 2026
- COURT-RULING reportAug 22, 2026
- COURT-RULING reportAug 18, 2026
- CLUSTER reportJul 17, 2026
- 8-K reportJul 15, 2026
- CLUSTER reportJun 15, 2026
- 8-K reportJun 10, 2026
- 8-K reportApr 22, 2026
- DEFA14A reportMar 27, 2026
- CLUSTER reportMar 23, 2026
- CLUSTER reportMar 9, 2026